Synthes Charged With Unauthorized Spine Repair Trial, Faces $34 Mil. Fine
This article was originally published in The Gray Sheet
Executive Summary
Orthopedic device maker Synthes and its Norian subsidiary face $34.8 million in potential fines for allegedly skirting FDA requirements and conducting unauthorized clinical trials of their Norian XR and Norian SRS bone cement for vertebral compression fractures
You may also be interested in...
Synthes To Pay $23 Million For Illegal Testing, Marketing Scheme
Orthopedic device maker Synthes and its subsidiary Norian will pay a total of $23.2 million in criminal penalties for conducting unauthorized clinical trials of its Norian XR and Norian SRS bone cement products
Synthes To Pay $23 Million For Illegal Testing, Marketing Scheme
Orthopedic device maker Synthes and its subsidiary Norian will pay a total of $23.2 million in criminal penalties for conducting unauthorized clinical trials of its Norian XR and Norian SRS bone cement products
FDA Targeting Execs With Criminal Charges For Adulterated/Misbranded Goods
FDA increasingly will prosecute corporate officers in response to criticism over the agency's handling of violations of the Federal Food, Drug & Cosmetic Act in recent years